Publication Details

Plasma osteopontin is an independent prognostic marker for head and neck cancers.

Petrik D, Lavori PW, Cao H, Zhu Y, Wong P, Christofferson E, Kaplan MJ, Pinto HA, Sutphin P, Koong AC, Giaccia AJ, Le QT. J Clin Oncol. 2006; 24 (33): 5291-7

To confirm the relationship between plasma osteopontin (OPN) levels and treatment outcomes in head and neck squamous cell carcinoma (HNSCC) patients in an expanded study.

PubMedID: 17114663